Zhibo Ma

Zhibo Ma

Auto-generated profile, based on publicly available information

Zhibo Ma

Gene Expression Laboratory, Salk Institute for Biological Studies

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 September 2022 in Cancer Discovery
Verified
Journal Article
Closed access
PDF file
ELEllen Langille
Ellen Langille
KAKhalid N. Al-Zahrani
Khalid N. Al-Zahrani
ZMZhibo Ma
Zhibo Ma
MLMinggao Liang
Minggao Liang
LULiis Uuskula-Reimand
Liis Uuskula-Reimand
DSDaniel Schramek
Daniel Schramek
Systematically investigating the scores of genes mutated in cancer and discerning disease drivers from inconsequential bystanders is a prerequisite for precision medicine but remains challenging. Here, we developed a somatic CRISPR/Cas9 mutagenesis screen to study 215 recurrent “long-tail” breast cancer genes, which revealed epigenetic regulation as a major tumor-suppressive mechanism. We report that components of the BAP1 and COMPASS-like complexes, including KMT2C/D, KDM6A, BAP1, and ASXL1/2 (“EpiDrivers”), cooperate with PIK3CAH1047R to transform mouse and human breast epithelial cells. Mechanistically, we find that activation of PIK3CAH1047R and concomitant EpiDriver loss triggered an alveolar-like lineage conversion of basal mammary epithelial cells and accelerated formation of luminal-like tumors, suggesting a basal origin for luminal tumors. EpiDriver mutations are found in ∼39% of human breast cancers, and ∼50% of ductal carcinoma in situ express casein, suggesting that lineage infidelity and alveogenic mimicry may significantly contribute to early steps of breast cancer etiology. Significance: Infrequently mutated genes comprise most of the mutational burden in breast tumors but are poorly understood. In vivo CRISPR screening identified functional tumor suppressors that converged on epigenetic regulation. Loss of epigenetic regulators accelerated tumorigenesis and revealed lineage infidelity and aberrant expression of alveogenesis genes as potential early events in tumorigenesis. This article is highlighted in the In This Issue feature, p. 2711

18 December 2014 in The Journal of Physical Chemistry C
Verified
Journal Article
Closed access
XMXinchun Mao
Xinchun Mao
DWDong Wei
Dong Wei
ZWZhiqiang Wang
Zhiqiang Wang
XJXianchi Jin
Xianchi Jin
QHQunqing Hao
Qunqing Hao
XYXueming Yang
Xueming Yang

17 February 2022
Verified
Book Chapter
Open access
PDF file
ZMZhibo Ma
Zhibo Ma
NLNikki K. Lytle
Nikki K. Lytle
CGCynthia De la Garza
Cynthia De la Garza
RNRazia F. Naeem
Razia F. Naeem
GWGeoffrey M. Wahl
Geoffrey M. Wahl
Cancers are caricatures of normal development. Yet, for most organs we are only beginning to learn about the molecular events underlying the embryonic antecedents of organogenesis and when differentiation into the cell types found in the adult actually begins. Here, we will focus on the powerful single-cell RNA sequencing and Assay for Transposase Accessible DNA by DNA sequencing (ATAC-seq) that we and others have been using to decipher the key regulators and signal transduction pathways involved in normal mammary development. We will first describe the techniques we use to identify, dissect, and isolate embryonic mammary rudiments and their constituent cells. We then describe the methods we have employed to perform single-cell RNA-seq and single-nucleus ATAC-seq using the small number of cells obtainable from mouse embryos. Finally, we will discuss the bioinformatic techniques we have used to interpret the vast amount of data obtained with these methods. Key words Fetal mammary gland Mammary rudiments Single-cell RNA-seq Single-nucleus ATAC-seq Integrated analysis Bioinformatic analysis

9 October 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
QVQueralt Vallmajo-Martin
Queralt Vallmajo-Martin
ZMZhibo Ma
Zhibo Ma
SSSumana Srinivasan
Sumana Srinivasan
DMDivya Murali
Divya Murali
CDChristopher Dravis
Christopher Dravis
NLNikki K. Lytle
Nikki K. Lytle
Summary: The adult mammary gland is maintained by lineage-restricted progenitor cells through pregnancy, lactation, involution, and menopause. Injury resolution, transplantation-associated mammary gland reconstitution, and tumorigenesis are unique exceptions, wherein mammary basal cells gain the ability to reprogram to a luminal state. Here, we leverage newly developed cell-identity reporter mouse strains, and time-resolved single-cell epigenetic and transcriptomic analyses to decipher the molecular programs underlying basal-to-luminal fate switching in vivo . We demonstrate that basal cells rapidly reprogram toward plastic cycling intermediates that appear to hijack molecular programs we find in bipotent fetal mammary stem cells and puberty-associatiated cap cells. Loss of basal-cell specifiers early in dedifferentiation coincides with activation of Notch and BMP, among others. Pharmacologic blockade of each pathway disrupts basal-to-luminal transdifferentiation. Our studies provide a comprehensive map and resource for understanding the coordinated molecular changes enabling terminally differentiated epithelial cells to transition between cell lineages and highlights the stunning rapidity by which epigenetic reprogramming can occur in response to disruption of tissue structure.

4 April 2023
Verified
Other
Open access
ELEllen Langille
Ellen Langille
KAKhalid N. Al-Zahrani
Khalid N. Al-Zahrani
ZMZhibo Ma
Zhibo Ma
MLMinggao Liang
Minggao Liang
LULiis Uuskula-Reimand
Liis Uuskula-Reimand
DSDaniel Schramek
Daniel Schramek
Systematically investigating the scores of genes mutated in cancer and discerning disease drivers from inconsequential bystanders is a prerequisite for precision medicine but remains challenging. Here, we developed a somatic CRISPR/Cas9 mutagenesis screen to study 215 recurrent “long-tail” breast cancer genes, which revealed epigenetic regulation as a major tumor-suppressive mechanism. We report that components of the BAP1 and COMPASS-like complexes, including KMT2C/D, KDM6A, BAP1, and ASXL1/2 (“EpiDrivers”), cooperate with PIK3CAH1047R to transform mouse and human breast epithelial cells. Mechanistically, we find that activation of PIK3CAH1047R and concomitant EpiDriver loss triggered an alveolar-like lineage conversion of basal mammary epithelial cells and accelerated formation of luminal-like tumors, suggesting a basal origin for luminal tumors. EpiDriver mutations are found in ∼39% of human breast cancers, and ∼50% of ductal carcinoma in situ express casein, suggesting that lineage infidelity and alveogenic mimicry may significantly contribute to early steps of breast cancer etiology.Significance:Infrequently mutated genes comprise most of the mutational burden in breast tumors but are poorly understood. In vivo CRISPR screening identified functional tumor suppressors that converged on epigenetic regulation. Loss of epigenetic regulators accelerated tumorigenesis and revealed lineage infidelity and aberrant expression of alveogenesis genes as potential early events in tumorigenesis.This article is highlighted in the In This Issue feature, p. 2711

4 April 2023
Verified
Other
Open access
ELEllen Langille
Ellen Langille
KAKhalid N. Al-Zahrani
Khalid N. Al-Zahrani
ZMZhibo Ma
Zhibo Ma
MLMinggao Liang
Minggao Liang
LULiis Uuskula-Reimand
Liis Uuskula-Reimand
DSDaniel Schramek
Daniel Schramek
Supplementary Data from Loss of Epigenetic Regulation Disrupts Lineage Integrity, Induces Aberrant Alveogenesis, and Promotes Breast Cancer